Brief: Abcellera’s First Program With Regeneron Advances In Preclinical Development
Nov 2 (Reuters) -
* ABCELLERA’S FIRST PROGRAM WITH REGENERON IN MULTI-TARGET
COLLABORATION ADVANCES IN PRECLINICAL DEVELOPMENT
Source text for Eikon: ID:nBw3QMkga
Further company coverage: [ ]
((Reuters.Briefs@thomsonreuters.com;))
Recent news on AbCellera Biologics
See all newsAbCellera Biologics Inc. reports results for the quarter ended September 30 - Earnings Summary
Canada's AbCellera Q3 revenue beats analyst estimates
Factbox: Pharma sector doubles down on AI to slash costs, timelines
U.S. STOCKS ON THE MOVE-Tapestry, Cisco, Sandisk
U.S. STOCKS ON THE MOVE-EnerSys, Netflix, Salesforce